krds peptide has been researched along with tetradecanoylphorbol acetate in 1 studies
| Studies (krds peptide) | Trials (krds peptide) | Recent Studies (post-2010) (krds peptide) | Studies (tetradecanoylphorbol acetate) | Trials (tetradecanoylphorbol acetate) | Recent Studies (post-2010) (tetradecanoylphorbol acetate) |
|---|---|---|---|---|---|
| 10 | 0 | 0 | 31,050 | 61 | 2,217 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caen, J; Fiat, AM; Hermant, L; Jollès, P; Lévy-Toledano, S; Lu, H; Mazoyer, E; Rendu, F | 1 |
1 other study(ies) available for krds peptide and tetradecanoylphorbol acetate
| Article | Year |
|---|---|
KRDS, a new peptide derived from human lactotransferrin, inhibits platelet aggregation and release reaction.
Topics: Adenosine Diphosphate; Amino Acid Sequence; Antibodies, Monoclonal; Blood Platelets; Calcium; Fibrinogen; In Vitro Techniques; Lactoferrin; Molecular Sequence Data; Oligopeptides; Peptide Fragments; Phosphatidylinositols; Phosphoproteins; Phosphorylation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Protein Conformation; Serotonin; Signal Transduction; Tetradecanoylphorbol Acetate; Thrombin | 1990 |